CYT-1010 is an μ-opioid receptor ligand potentially for the treatment of acute and chronic pain and neuropathic pain syndrome.
CAT No: 10-101-237
CAS No:213769-33-6
Synonyms/Alias:CYT-1010;23FM92X9QD;213769-33-6;UNII-23FM92X9QD;CHEMBL5186493;L-Phenylalanine, L-tyrosyl-D-lysyl-L-tryptophyl-, (4->2)-lactam;(2S)-2-amino-N-[(3S,6S,9R)-3-benzyl-6-(1H-indol-3-ylmethyl)-2,5,8-trioxo-1,4,7-triazacyclotridec-9-yl]-3-(4-hydroxyphenyl)propanamide;SCHEMBL19236018;BDBM50594830;DA-52267;HY-123534;CS-0082931;
Chemical Name:2-amino-N-[3-benzyl-6-(1H-indol-3-ylmethyl)-2,5,8-trioxo-1,4,7-triazacyclotridec-9-yl]-3-(4-hydroxyphenyl)propanamide
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.